Expression of PD-1 and PD-L1 on Tumor-Infiltrating Lymphocytes Predicts Prognosis in Patients with Small-Cell Lung Cancer

INTRODUCTION: Immune therapy has shown good results in small-cell lung cancer (SCLC), but the impact of immune microenvironment of the disease is unclear. In this work, we detected expression of programmed death 1 (PD-1), PD-ligand 1 (PD-L1), and other immune biomarkers of cancer. We also analyzed t...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Chenglong, Zhang, Liping, Zhang, Wei, Liu, Yu, Chen, Bin, Zhao, Sha, Li, Wei, Wang, Lei, Ye, Lingyun, Jia, Keyi, Wang, Hao, Wu, Chunyan, He, Yayi, Zhou, Caicun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342461/
https://www.ncbi.nlm.nih.gov/pubmed/32753888
http://dx.doi.org/10.2147/OTT.S252031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342461/
https://www.ncbi.nlm.nih.gov/pubmed/32753888
http://dx.doi.org/10.2147/OTT.S252031

Ejemplares similares